Cardicomm Solutions, Inc. Press Releases

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced the appointment of Dr. John Foote, MD, CCFP(EM) from Mount Sinai Hospital, Toronto, Ontario, as the newest member of the Company’s Board of Directors ("BOD") and the resignation of BOD member Mr. William Smith. The Company confirms it expects to...

Palm Desert, CA, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cytta Corp. (OTCPINK:CYCA), a leading provider of mobile smartphone and web based healthcare technology solutions, and CardioComm Solutions, Inc. ("CardioComm") (TSX VENTURE:EKG), a Canada based global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software and hardware solutions, today announced completion of a Joint Venture Agreement ("Agreement"). Under the announced Agreement both parties...

TORONTO, ONTARIO - a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") management software solutions, today announced that it has completed a custom software engineering contract with UK based Remote Diagnostic Technologies Limited ("RDT") for development and licensing of a remote, cloud-based, 12 lead ECG management and ECG reading solution. RDT specializes in the design of highly integrated mobile, vital signs, tele-monitoring solutions...

TORONTO, ONTARIO - Established medical electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company"), today announced it has received the ACQ5 award as the Niche Technology Company of the Year in the Healthcare and Telemedicine category. The ACQ5 2017 award is sponsored by Acquisition Finance which is published under license from the Metropolis International Group Ltd. The magazine is circulated...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”)a leading global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, released its second quarter 2017 financials demonstrating continued sales growth, a profitable 2017 year to date, and a net profitable position over the past four fiscal quarters. The Q2 numbers are the result of...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”)a leading global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced it has integrated its ECG viewer and Smart Monitoring ECG service with telemedicine provided by France based Visiomed Group SA ("Visiomed"). Under the annual, renewable software license agreement (the...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a leading global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced it has been awarded a $567,079 grant from the Canada-Israel Industrial Research and Development Foundation ("CIIRDF") to enable R&D collaborations with HealthWatch Technologies Ltd. ("HealthWatch") of...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a consistent, global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, released its first quarter 2017 financials and confirms its strongest fiscal performance continues with a profitable start to 2017. The Company's management continues to maintain control over expenses while protecting...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of consumer heart monitoring and medical electrocardiogram software solutions, today announced that it has granted an aggregate of 1,000,000 stock options to the directors of the Company as remuneration for their contributions to the Company as members of the board and board committees. The options are exercisable...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a consistent, global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today released its 2016 year end financials and confirms its strongest fiscal performance yet. The Company's management has worked to successfully reduce expenses while maintaining overall revenue...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a consistent, global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced it has entered into a development, distribution and co-marketing agreement with Israel-based HealthWatch Technologies Ltd. ("HealthWatch") for the development, sales and marketing of a smart shirt based...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced a partnership with CareSpan USA Inc., a leading provider of digital healthcare delivery systems, entered into on April 21, 2017. Under the agreement the parties have agreed to integrate CardioComm's cloud-based...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has closed its previously announced equity financing for gross proceeds of $76,000. The equity financing was conducted to allow parties who were not able to participate in the Company’s December 2016 private placement to invest in the Company. The proceeds from the financing will be used for general operations,...

Financing allows investment by parties not able to participate in December, 2016 equity raise TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it is conducting a non-brokered private placement equity financing under which it intends to issue up to 3,000,000 units at a price of $0.05 per unit for gross proceeds of up to $150,000. Each unit will be comprised of one...

Private placement remains open while the Company readies efforts for new initiatives in 2017 TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has closed its previously announced debt financing of $600,000 and the first tranche of its previously announced equity financing for gross proceeds of $500,000. Under the terms of the debt financing, the Company has borrowed...

$1.169M in debt and equity fundraising and debt reduction is the foundation for continued growth in 2017 TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that the Company is: Conducting a non-brokered debt financing under which it intends to raise up to $600,000; Intending to close the first $500,000 tranche of its $650,000 private placement initiative announced December...

Increased investment market exposure to complement immediate and long- term financing objectives TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it is conducting a non-brokered private placement equity financing under which it intends to issue up to 13,000,000 units at a price of $0.05 per unit, for gross proceeds of up to $650,000. The Company’s shares have...

Increased investment market exposure to complement immediate and long- term financing objectives TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today announced that it has engaged the services of FronTier Merchant Capital Group ("FronTier") to provide it with...

Veteran of J&J's M&A Group to bring additional partnership generation and financial sourcing skills to Board TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm” or the “Company”), a global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today announced the appointment of Ms. Margaret (Meg) Helms as the newest member of the Company’s  Board of...

Q1-Q3 2016 fiscal performance represents best nine-month period in 17 years TORONTO, ONTARIO - Medical electrocardiogram (“EKG”) software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm” or the “Company”), has released its Q3 2016 financials, which reflect revenue-positive performance and the best fiscal performance for any nine-month period in the Company’s 17-year history. A summary of the...

Use of HeartCheck™ device sales and long-term ECG monitoring services will increase physician reimbursements through established billing codes TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today announced it has entered into a three year agreement for sales of the...

Award recognizes innovation and advances in global Health and Medical Wellness markets. Other winners include Uber, Riot Games, Google, Microsoft and Airbnb TORONTO, ONTARIO - Established medical electrocardiogram (“ECG”) software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), today announced it has been awarded the 2017 Innovation and Excellence Award for Best in Medical...

Past investments in product development to reap profits - New products pipeline to grow top line - Continuing prudent fiscal management to cut costs TORONTO, ONTARIO - Medical electrocardiogram (“EKG”) software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm” or the “Company”), confirms it has received notice from MD Primer Inc. (“MDP”) that a $900,000 line of credit (“LOC”), which...

Company plans to start 2017 with next-generation consumer products and a new fiscal outlook TORONTO, ONTARIO - Medical electrocardiogram (“EKG”) software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm” or the “Company”), today confirmed the appointment of Mr. Robert Caines as the Chairman of its Board of Directors, replacing Dr. Anatoly Langer, who steps down from the position held since March 5, 2008. Mr....